Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gloria Pérez-Rus"'
Autor:
Francisco Cervantes, Pilar López-Garrido, María-Isabel Montero, Fermín Jonte, Jesús Martínez, Juan-Carlos Hernández-Boluda, María Calbacho, Anna Sureda, Gloria Pérez-Rus, José B. Nieto, Cristina Pérez-López, José Román-Gómez, Marcos González, Arturo Pereira, Dolors Colomer
Publikováno v:
Haematologica, Vol 95, Iss 8 (2010)
Background Despite the favorable results of imatinib front line in chronic-phase chronic myeloid leukemia there is room for improvement.Design and Methods Early intervention during imatinib therapy was undertaken in 210 adults with chronic-phase chro
Externí odkaz:
https://doaj.org/article/04520569803c47f880d07abf7ee18134
Autor:
Maite Chasco-Ganuza, Sara Casanova-Prieto, Gloria Pérez-Rus, Cristina Pascual-Izquierdo, José Luis Díez-Martín, Patricia Duque-González, Valeria Estefanía Delgado-Pinos, Reyes María Martín-Rojas, Milagros Sancho
Publikováno v:
Blood Coagulation & Fibrinolysis
Early descriptions of COVID-19 associated coagulopathy identified it as a disseminated intravascular coagulation (DIC). However, recent studies have highlighted the potential role of endothelial cell injury in its pathogenesis, and other possible und
Autor:
Maite Chasco-Ganuza, Carolina Almaraz, Patricia Duque, Gloria Pérez-Rus, Ariana Ortuzar, Cristina Pascual, Estrella Terradillos
Publikováno v:
Thrombosis and Haemostasis. 122:048-056
Background A factor XIII (FXIII) level >30% is considered necessary to prevent spontaneous bleeding. Bleeding is also a risk in patients with acquired FXIII deficiency, but the hemostatic level of FXIII in this context remains to be determined. Metho
Autor:
Gloria Pérez-Rus, Isabel Regalado-Artamendi, Ana Pérez-Corral, Amalia Domingo-González, José Luis Díez-Martín, Reyes María Martín-Rojas, Cristina Pascual-Izquierdo
Publikováno v:
Journal of Clinical Apheresis. 36:420-428
Acquired thrombotic thrombocytopenic purpura (aTTP) is still associated with a 10% to 20% death rate and its clinical course is characterized by recurrent episodes in up to 50% of cases. Over the last decade, mortality predicting models like the Fren
Autor:
Amalia, Domingo-González, Isabel, Regalado-Artamendi, Reyes María, Martín-Rojas, Gloria, Pérez-Rus, Ana, Pérez-Corral, José Luis, Díez-Martín, Cristina, Pascual-Izquierdo
Publikováno v:
Journal of clinical apheresisREFERENCES. 36(3)
Acquired thrombotic thrombocytopenic purpura (aTTP) is still associated with a 10% to 20% death rate and its clinical course is characterized by recurrent episodes in up to 50% of cases. Over the last decade, mortality predicting models like the Fren
Autor:
Isabel, Regalado-Artamendi, Ana M, Pérez-Corral, Marina, García-Morín, Elena, Cela, Cristina, Beléndez, Eduardo J, Bardón-Cancho, Gloria, Pérez-Rus, Isabel, Pérez-Sánchez, Cristina, Pascual, Silvia, Monsalvo, Carmen, Falero, Jose L, Díez-Martín, Javier, Anguita
Publikováno v:
Blood Transfus
BACKGROUND: Red blood cell (RBC) transfusion remains an essential part of sickle cell disease (SCD) management but it can lead to alloimmunisation, with an increased incidence in this population. Prevention is based on RBC antigen phenotype matching,
Autor:
Isidro Jarque, Erik de Cabo, Marta Gómez-Nuñez, Elsa López-Ansoar, Gloria Pérez-Rus, María Yera Cobo, Fernando Fernández-Fuertes, Germán Perdomo, Pável E Olivera, María Jesús Peñarrubia, Estefanía Bolaños, María Paz Martínez Badas, Isabel Caparrós, Blanca Sanchez-Gonzalez, Angeles Fernández-Rodríguez, Luis Javier García-Frade, Tomás José González-López, Carmen Fernández-Miñano, Jose Angel Hernandez-Rivas, Silvia Bernat, Inmaculada Soto, Violeta Martínez-Robles, Cristina Pascual
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Universidad de Almería
EUROPEAN JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Universidad de Almería
EUROPEAN JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO. Repositorio Institucional de Producción Científica
[Background]: Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality. Here we evaluated eltrombopag for primary and secondary ITP in our ≥65‐year‐old popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db91a8b053c596692384d95d1bbdd342
http://hdl.handle.net/10261/220424
http://hdl.handle.net/10261/220424
Autor:
Isabel Gutiérrez, Gloria Pérez-Rus, Begoña Fernández, Belén Rosado Sierra, Susana Asenjo Correa, María Elena Sola Aparicio, Mar Meijón, Paola Alejandra Barzallo Burbano, Ramón Rodríguez-González, José Luis Díez-Martín, Maria Pilar Llamas Sillero, María Jesús Blanco Bañares, Nuria Revilla Calvo, Cristina Pascual Izquierdo
Publikováno v:
Blood. 138:2134-2134
Introduction: Idarucizumab is a humanized monoclonal antibody fragment that binds to dabigatran and reverses its anticoagulant activity. It has been available in Spain since June 2016 and is indicated for imminent surgery or invasive procedures and l
Autor:
Reyes María Martín-Rojas, José Luis Díez-Martín, Valeria Estefanía Delgado-Pinos, Patricia Duque, Gloria Pérez-Rus, Cristina Pascual Izquierdo, Sara Casanova, Maite Chasco, Milagros Sancho
Publikováno v:
Blood
INTRODUCTION COVID-19 is associated with coagulopathy that correlates with poor prognosis. Although the underlying mechanism of COVID-19 coagulopathy remains unknown, early reports suggested that it may be a form of disseminated intravascular coagula
Autor:
María Perera, Montserrat Cortés, Erika Coria, Miguel Angel Fuertes-Palacio, Laura Solán, Isabel Caparrós, Inés Valcarce, Isidro Jarque, Carlos Aguilar, R. Jiménez, Pilar Galan, Silvia Bernat, Tomás José González-López, Pável E Olivera, Mónica Martín-Salces, Adriana Sainz, María Carmen Arratibel, María Paz Martínez-Badas, Maria Eva Mingot-Castellano, Manuel González-Silva, Fernando Fernández-Fuertes, Rafael Feito Alonso, Erik de Cabo, Juan Andrés Vázquez-Paganini, Angeles Fernández-Rodríguez, Susana Pérez-Crespo, Paola Beneit, Carmen Fernández-Miñano, Rosa Fisac, Carmen de Cos, Maria José Cortti, Violeta Martínez-Robles, Jose Angel Hernandez-Rivas, Alberto Casaus, Armando Luaña, Isabel Gutierrez-Jomarrón, Arancha Alonso, Cristina Fernández-Canal, María Teresa Álvarez-Román, María Jesús Peñarrubia, Javier García-Frade, Marcio M Andrade, José Ramón González-Porras, Marta Gómez-Nuñez, María Calbacho, Gloria Pérez-Rus, Cristina Pascual, Blanca Sanchez-Gonzalez
Publikováno v:
American Journal of Hematology. 90:E40-E43
Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the frequency of this phenomenon is unknown. We retrospectively evaluated 260 adult primary ITP pati